| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |